Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Phase: N/A Priority: Normal
NCT ID: NCT03164967 Org: User:
Start: 12/29/16 End: 12/31/22 Due: 12/31/23

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Phase: N/A Priority: Normal
NCT ID: NCT01814800 Org: User:
Start: 02/28/14 End: 01/31/15 Due: 01/31/16

RI-001 in Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV Illness

Phase: N/A Priority: Normal
NCT ID: NCT00632463 Org: User:
Start: 02/29/08 End: 05/31/10 Due: 05/31/11

Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)

Phase: N/A Priority: Normal
NCT ID: NCT00538915 Org: User:
Start: 09/30/07 End: 07/31/09 Due: 07/31/10

An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)

Phase: N/A Priority: Normal
NCT ID: NCT05070455 Org: User:
Start: 09/01/22 End: 06/30/23 Due: 06/30/24

A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products

Phase: N/A Priority: Normal
NCT ID: NCT03037359 Org: User:
Start: 12/31/16 End: 06/30/23 Due: 06/30/24

Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00473824 Org: User:
Start: 05/31/07 End: 02/28/09 Due: 02/28/10